CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.00015
+0.00005 (50.00%)
At close: Sep 29, 2026
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $288.87 thousand as of September 29, 2026. Its market cap has increased by 27.84% in one year.
Market Cap
288.87K
Enterprise Value
1.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 288.87K, an increase of 21.34%. That is a compound annual growth rate of 1.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 288.87K | -4.12% |
| Dec 31, 2025 | 301.28K | 30.86% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| MetaStat | 319.73K |
| Burzynski Research Institute | 256.32K |
| Ampio Pharmaceuticals | 207.88K |
| Ocean Biomedical | 185.89K |
| Regen BioPharma | 167.53K |
| Affymax | 119.18K |